Feasibility of [(18)F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type KRAS Colorectal Cancer

Early response assessment is critical for personalizing cancer therapy. Emerging therapeutic regimens with encouraging results in the wild-type (WT) KRAS colorectal cancer (CRC) setting include inhibitors of epidermal growth factor receptor (EGFR) and glutaminolysis. Towards predicting clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Seong-Woo, Wang, Jianbo, Georgiou, Dimitra K., Wen, Xiaoxia, Cohen, Allison S., Geng, Ling, Tantawy, Mohammed Noor, Manning, H. Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037609/
https://www.ncbi.nlm.nih.gov/pubmed/36961000
http://dx.doi.org/10.3390/tomography9020041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037609/
https://www.ncbi.nlm.nih.gov/pubmed/36961000
http://dx.doi.org/10.3390/tomography9020041

Ejemplares similares